Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 4:12 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 417 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Diabetic Ulcers Clear all

Conditions: Diabetes Complications, Diabetes, Diabetic Foot Ulcer, Wound Infection
Interventions: Telcare 2.0 BGM; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Diabetic Foot Ulcer, Venous Leg Ulcer, Surgical Wound Dehiscence, Traumatic Wounds
Interventions: Study Device Debridement, SOC Debridement; Device
Lead sponsor: Medaxis, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Bradenton, Florida

Conditions: Diabetic Foot Ulcer
Interventions: TheraGauze, Regranex; Device · Drug
Lead sponsor: Solsys Medical LLC; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Diabetes, Diabetic Foot Ulcer, Peripheral Neuropathy, Peripheral Arterial Disease
Interventions: Electrical Stimulation - Active, Electrical Stimulation - Sham; Device
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years to 85 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Diabetic Foot Ulcers (DFUs), Chronic Wound of the Lower Limb (Leg Ulcer or Foot Ulcer)
Interventions: Miro3D Wound Matrix, Standard of Care (SOC); Device · Other
Lead sponsor: Reprise Biomedical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 3
States / cities: Coconut Creek, Florida • Tamarac, Florida • New York, New York

Conditions: Diabetic Foot, Diabetic Foot Ulcer, Wound; Foot, Wound Leg, Wound Heal, Diabetes Complications
Interventions: Remote wound monitoring technology; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 148 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Wounds, Diabetes Complications, Diabetic Foot, Foot Ulcer
Interventions: Online Wound Electronic Medical Record; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 1,609 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 13
States / cities: Phoenix, Arizona • Tuscon, Arizona • Pomona, California + 8 more

Conditions: Diabetic Foot Ulcer
Interventions: 0.03% DSC127 topical gel; Drug
Lead sponsor: Integra LifeSciences Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 261 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 21
States / cities: Mobile, Alabama • Chino, California • Fresno, California + 16 more

Conditions: Diabetic Foot Ulcers
Interventions: Affinity Allograft, Standard of care; Other
Lead sponsor: Organogenesis; Industry
Eligibility: 18 Years and older
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 8
States / cities: Miami Lakes, Florida • North Miami Beach, Florida • Clinton Township, Michigan + 5 more

Conditions: Lower Extremity Chronic Ulcers in Diabetics, Diabetic Foot Ulcer (DFU)
Interventions: amniotic membrane; Other
Lead sponsor: Tides Medical; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 5
States / cities: North Port, Florida • Buffalo, New York • Monroeville, Pennsylvania + 2 more

Conditions: Diabetic Foot Ulcers (DFUs)
Interventions: Antimicrobial agent; Drug
Lead sponsor: Lakewood-Amedex Inc; Industry
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 6
States / cities: Los Angeles, California • Doral, Florida • Margate, Florida + 3 more

Conditions: Diabetic Foot Ulcer
Interventions: Lavior Diabetic Wound Gel, Smith & Nephew Solosite Gel Hydrogel Wound Dressing; Drug
Lead sponsor: Lavior Pharma Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Diabetic Foot Ulcer
Interventions: TRS; Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 80 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Diabetic Foot Ulcers
Interventions: Omeza collagen matrix, Omeza lidocaine lavage, Omeza skin protectant; Combination Product
Lead sponsor: Omeza, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Toledo, Ohio

Conditions: Pressure Ulcers, Venous Ulcers, Diabetic Ulcers, Surgical Wounds, Trauma Wounds
Interventions: PuraPly™ Antimicrobial Wound Matrix; Device
Lead sponsor: Organogenesis; Industry
Eligibility: 18 Years and older
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Lake Success, New York

Conditions: Diabetic Foot Ulcer, Venous Leg Ulcer, Pressure Ulcer, Wound, Non-Healed
Interventions: DETEC® pH; Diagnostic Test
Lead sponsor: Progenitec Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Lake Success, New York • Arlington, Texas

Conditions: Diabetic Foot Ulcers, Wound Care
Interventions: AmnioClear™ Human Allograft Amniotic Membrane; Biological
Lead sponsor: Liventa Bioscience; Industry
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Diabetic Foot Ulcer, DFU, Diabetic Foot Ulcer (DFU), Foot Ulcer Due to Type 1 Diabetes Mellitus, Foot Ulcer Due to Type 2 Diabetes Mellitus, Ulcer, Ulcer Foot
Interventions: Activate™ Matrix, AmnioDefend™ FT Matrix, Palisade™ DM Matrix, Enclose™ TL Matrix, Sentry™ SL Matrix, Shelter™ DM Matrix + SOC; Other
Lead sponsor: Sequence LifeScience, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Monroeville, Pennsylvania

Conditions: Bacterial Infections, Diabetic Foot, Osteomyelitis
Interventions: Tigecycline, Ertapenem; Drug
Lead sponsor: Wyeth is now a wholly owned subsidiary of Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 1,061 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 26
States / cities: Los Angeles, California • Northridge, California • San Francisco, California + 20 more

Conditions: Diabetic Wounds, Venous Stasis Wounds
Interventions: injection of lipoaspirate, control; Procedure · Other
Lead sponsor: Washington D.C. Veterans Affairs Medical Center; Federal
Eligibility: 20 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Wounds, Leg Ulcers, Pressure Ulcers, Diabetic Foot Ulcers
Interventions: AutoloGel System; Device
Lead sponsor: Cytomedix; Industry
Eligibility: 18 Years to 95 Years
Enrollment: 131 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2012
U.S. locations: 2
States / cities: Augusta, Georgia • El Paso, Texas

Conditions: Diabetic Foot Ulcers, Pressure Ulcers
Interventions: HP828-101, Hydrogel/Hydrocolloid; Device
Lead sponsor: Healthpoint; Industry
Eligibility: 18 Years and older
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 11
States / cities: Bakersfield, California • Chula Vista, California • Fresno, California + 7 more

Conditions: Diabetes, Ulceration, Amputation, Foot Deformity, Neuropathy
Interventions: pressure reducing insole, GlideSoft®; Device
Lead sponsor: Diabetica Solutions Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 299 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2005
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Diabetic Foot Ulcer (DFU)
Interventions: Xcell Amnio Matrix, Standard of Care (SOC); Biological · Drug
Lead sponsor: New Horizon Medical Solutions; Network
Eligibility: 18 Years and older
Enrollment: 135 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 3
States / cities: Fresno, California • San Diego, California • Dallas, Texas

Search by objective public record fields.

Diabetic Foot Ulcer and Wound Infection

Real World Evidence with the Debritom+ TM Novel Micro Water Jet Technology At a Single Wound Center

TheraGauze™ Alone and Regranex®Gel 0.01% Plus TheraGauze™ in the Treatment of Wagner Stage I Diabetic Foot Ulcers

Electrical Stimulation to Accelerate Wound Healing

Miro3D Wound Matrix Study for Diabetic Foot Ulcers and Wound Healing

Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers

Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics

Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use

Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot Ulcers

Artacent Amniotic Tissue for Treatment of Chronic Lower Extremity Diabetic Ulcers.

Phase 2a Dose Finding Study of Nu-3 Gel in Subjects With Mild iDFU

Restoring Tissue and Evaluating Novel Treatments for Efficacy in Wounds

Transcutaneous Raman Spectroscope (TRS) Analyses of Diabetic Foot Ulcers

Omeza Products in Combination With Standard of Care for the Treatment of Diabetic Foot Ulcers

Prospective PuraPly™ AM Case Series Study

DETEC® pH Point of Care Wound Diagnostic Test

A Randomized Comparison of AmnioClear™ Human Allograft Amniotic Membrane vs. Moist Wound Dressing in the Treatment of Diabetic Wounds

Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy

Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.

The Role of Lipoaspirate Injection in the Treatment of Diabetic Lower Extremity Wounds and Venous Stasis Ulcers

The AutoloGel™ Post-Market Surveillance (TAPS) Program

Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness Wounds

Shear and Pressure Reducing Insoles for the Diabetic Foot

A Prospective Clinical Study to Evaluate the Effectiveness and Safety of Xcell Amnio MatrixTM (XAM) in the Management of Chronic Non-healing DFUs